Stock Comparison
ONC vs VRTX
BeiGene, Ltd. and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$29.04B
$124.70B
P/E (TTM)
63.3
29.2
Forward P/E
45.5
25.8
Price/Sales
5.1
10.2
Price/Book
6.1
6.4
EV/EBITDA
29.7
24.0
Dividend Yield
—
—
Profitability
Net Margin
8.94%
35.50%
Operating Margin
16.50%
38.10%
Return on Equity
12.40%
24.20%
Return on Assets
5.96%
12.10%
Growth (YoY)
Revenue Growth
35.50%
7.80%
Earnings Growth
16971.00%
61.40%
Price & Risk
Beta
0.5
0.3
52-Week High
$385.22
$507.92
52-Week Low
$239.25
$362.50
Analyst Target
$412.35
$548.69
Compare ONC and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.